Adrian Gottschalk is President and Chief Executive Officer of Foghorn Therapeutics Inc. (FHTX). The company reported total compensation of $2,361,027 for fiscal year 2025.
| Salary | $638,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $0 |
| Option awards | $1,334,037 |
| Non-equity incentive plan | $385,990 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $3,000 |
| Total | $2,361,027 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Foghorn Therapeutics Inc. filed April 30, 2026, accession 0001193125-26-193928.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | President and Chief Executive Officer | $638,000 | $0 | $0 | $1,334,037 | $385,990 | $0 | $3,000 | $2,361,027 |
| FY2024 | President and Chief Executive Officer | $601,500 | $0 | $0 | $673,861 | $281,201 | $0 | $3,000 | $1,559,562 |
Totals as disclosed in each year's own compensation disclosure for Foghorn Therapeutics Inc..
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Adrian Gottschalk this page | President and Chief Executive Officer | $2,361,027 |
| Steven Bellon | Chief Scientific Officer | $1,199,455 |
| Alfonso Quintas-Cardama | Chief Medical Officer | $1,133,965 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Foghorn Therapeutics Inc. compensation brief.
Adrian Gottschalk's compensation sits inside Foghorn Therapeutics Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.